#11
|
||||
|
||||
Залез в полный текст ГИССИ: вот что там
In the absence of evidence for preferred doses of treatments, we decided on the daily doses of n-3 PUFA as 1 gelatin capsule containing 850–882 mg eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as ethyl esters in the average ratio of EPA/DHA 1:2... и в конце This study was supported by grants from Bristol-Myers Squibb, Pharmacia-Upjohn, Società Prodotti Antibiotici, and Pfizer. Pharmacia-Upjohn and Società Prodotti Antibiotici supplied marketed capsules containing 850–882 mg EPA/DHA ethyl esters. какова судьба Pharmacia-Upjohn не знаете? нашел - купили Пфайзер в 2002...
__________________
Искренне, Вадим Валерьевич. |